Pharmaceutics

Pharmacology, Toxicology and Pharmaceutical Science

1. Nanoparticle 100%
2. Bioavailability 74%
3. Antiinfective Agent 61%
4. Malignant Neoplasm 58%
5. Antioxidant 54%
6. Pharmacokinetic 52%
7. Anti-Inflammatory Drug 48%
8. Cytotoxicity 47%
9. Breast Cancer 39%
10. Drug Release 39%
11. Diseases 37%
12. Chitosan 36%
13. Tablet 35%
14. Drug Delivery System 35%
15. Zeta Potential 35%
16. Nanocarrier 33%
17. Nanoemulsion 32%
18. Inflammation 30%
19. Sustained Release 29%
20. Phytochemical 25%
21. Psoriasis 23%
22. Infection 22%
23. Wound Healing 20%
24. Differential Scanning Calorimetry 20%
25. Lung Cancer 20%
26. Scanning Electron Microscopy 20%
27. Essential Oil 20%
28. Antimicrobial Agent 20%
29. Antioxidant Capacity 19%
30. Antibacterial Activity 19%
31. Solid Lipid Nanoparticle 19%
32. IC50 17%
33. High Performance Liquid Chromatography 17%
34. Poloxamer 17%
35. Combination Therapy 17%
36. Receptor 16%
37. Neoplasm 16%
38. Cytokine 16%
39. Pseudomonas aeruginosa 16%
40. Staphylococcus aureus 15%
41. Methicillin-Resistant Staphylococcus Aureus 15%
42. Biological Marker 15%
43. Antibiotics 14%
44. Gold Nanoparticle 14%
45. Interleukin 6 14%
46. Parkinson's Disease 14%
47. Tumor Necrosis Factor 14%
48. Natural Product 13%
49. Nanogel 13%
50. Acetic Acid Ethyl Ester 13%
51. Untranslated RNA 13%
52. Rat Model 13%
53. Cyclodextrin 12%
54. Methanol 12%
55. Liposome 11%
56. Flavonoid 11%
57. Diabetes Mellitus 11%
58. Surfactant 11%
59. Infectious Agent 11%
60. Apremilast 11%
61. Diosmin 11%
62. Delafloxacin 11%
63. microRNA 11%
64. Carbon Dioxide 11%
65. Apigenin 10%
66. Rutin 10%
67. Polyglactin 10%
68. Simvastatin 10%
69. Non Small Cell Lung Cancer 10%
70. Antivirus Agent 10%
71. Silymarin 10%
72. Skin Infection 9%
73. Baricitinib 9%
74. Inflammatory Arthritis 9%
75. Rheumatoid Arthritis 9%
76. Metformin 9%
77. Curcumin 9%
78. Antiinflammatory Activity 9%
79. Drug Solubility 9%
80. Antidiabetic Agent 9%
81. Polyvinyl Alcohol 9%
82. Gallic Acid 9%
83. Ethyl Cellulose 9%
84. Diethylene Glycol Monoethyl Ether 9%
85. Ascorbic Acid 9%
86. Clinical Trial 9%
87. Glycyrrhizin 8%
88. Dosage Form 8%
89. Caspase 3 8%
90. Pharmacodynamics 8%
91. Drug Development 8%
92. Nephrotoxicity 8%
93. Atopic Dermatitis 8%
94. Reverse Phase High Performance Liquid Chromatography 8%
95. Silver Nanoparticle 8%
96. Antimicrobial Resistance 8%
97. Eudragit 8%
98. Biological Activity 7%
99. Propylene Glycol 7%
100. Mole (Insectivora) 7%